Status:
UNKNOWN
Biomarkers During Pregnancy
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Diabetes Mellitus in Pregnancy
Gestational Diabetes
Eligibility:
FEMALE
14-48 years
Brief Summary
This study aims to obtain preliminary data for utility of alternate biomarkers for monitoring glucose control in diabetic women during pregnancy and/or predicting risk of adverse neonatal events in th...
Detailed Description
This study aims to obtain preliminary data for utility of alternate biomarkers for monitoring glucose control in diabetic women during pregnancy and/or predicting risk of adverse neonatal events in th...
Eligibility Criteria
Inclusion
- All women included in the study will either have diabetes diagnosed before pregnancy or will have been diagnosed during pregnancy (GDM). We do not exclude minors, since in Missouri, they may consent to medical treatment without parental consent for medical issues relating to pregnancy,
Exclusion
- No specific exclusion criteria will be used. BMI data will be collected and utilized to sort patients into various subgroups, but will not be used as exclusion criteria.
Key Trial Info
Start Date :
March 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT04108455
Start Date
March 15 2019
End Date
November 30 2023
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University in St Louis
St Louis, Missouri, United States, 63110